United Pharmaceuticals Inc. has been delivering comprehensive clinical research support services to the global biopharmaceutical community. Our experienced, multidisciplinary teams are equipped to design, coordinate, analyze, and report clinical studies conducted at our facilities or in collaboration with external partners. Whether supporting an individual study or contributing to a broader development program, our research support services are structured to seamlessly complement your clinical strategy.
Speak With Our ExpertsAs a full-service Contract Research Organization (CRO), United Pharmaceuticals Inc. offers end-to-end oversight for early-phase through Phase Ib/IIa clinical trials. Our integrated model enables efficient trial execution through a single strategic partner, reducing operational complexity while maintaining scientific rigor.
Clients benefit from dedicated study leadership, customized service engagement, and a centralized point of contact with the expertise to manage every phase of clinical development. This streamlined approach ensures consistent communication, proactive risk management, and optimized timelines across your clinical programs.
The drug development environment continues to evolve rapidly, bringing increased scientific expectations, operational demands, and regulatory scrutiny. At the same time, clinical research programs face growing complexity across study design, execution, and compliance. Our mission is to help you navigate these challenges while accelerating the safe and efficient development of your therapeutic candidates.
United Pharmaceuticals Inc. specializes in coordinating a broad portfolio of clinical research support services with a focus on accountability, operational efficiency, and seamless integration. By aligning expertise across disciplines, we minimize redundancies, improve decision-making, and reduce the management burden for our partners.
Our services are designed to align smoothly with both standalone studies and broader clinical development programs. We work as an extension of your internal team, ensuring continuity, transparency, and efficient coordination across all stages of clinical research.
Yes. We routinely support studies conducted at external clinical sites, academic centers, and partner facilities. Our teams collaborate closely with third-party vendors to maintain consistent oversight, data quality, and regulatory compliance throughout the study lifecycle.
Our CRO services primarily support early-phase through Phase Ib/IIa clinical development, with scalable capabilities that can be adapted to meet evolving program needs. This allows sponsors to engage our expertise for single studies or integrated development pathways.
By combining clinical operations, regulatory expertise, laboratory sciences, and supporting infrastructure within a single organization, we reduce operational complexity and handoffs. This integrated approach enhances efficiency, improves accountability, and supports faster, well-controlled clinical development.